Artificial intelligence-driven real-time 3D surface quantification of Barrett's oesophagus for risk stratification and therapeutic response monitoring

BACKGROUND & AIMS: Barrett's epithelium measurement using widely accepted Prague C&M criteria is highly operator dependent. By reconstructing the surface of the Barrett's area in 3D from endoscopy video, we propose a novel methodology for measuring the C&M score automatically. This 3D reconstruction provides an extended field of view and also allows to precisely quantify the Barrett's area including islands. We aim to assess the accuracy of the extracted measurements from phantom and demonstrate their clinical usability. METHODS: Advanced deep learning techniques are utilised to design estimators for depth and camera pose required to map standard endoscopy video to a 3D surface model. By segmenting the Barrett's area and locating the position of the gastro-oesophageal junction (GEJ) we measure C&M scores and the Barrett's oesophagus areas (BOA). Experiments using a purpose-built 3D printed oesophagus phantom and high-definition video from 98 patients scored by an expert endoscopist are used for validation. RESULTS: Endoscopic phantom video data demonstrated a 95 % accuracy with a marginal +/- 1.8 mm average deviation for C&M and island measurements, while for BOA we achieved nearly 93 % accuracy with only +/- 1.1 sq. cm average deviation compared to the ground-truth measurements. On patient data, the C&M measurements provided by our system concord with the reference provided by expert upper GI endoscopists. CONCLUSIONS: The proposed methodology is suitable for extracting Prague C&M scores automatically with a high degree of accuracy. Providing an accurate measurement of the entire Barrett's area provides new opportunities for risk stratification and the assessment of therapy response.

[1]  C. Hassan,et al.  Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement , 2017, Endoscopy.

[2]  Zhengyou Zhang,et al.  A Flexible New Technique for Camera Calibration , 2000, IEEE Trans. Pattern Anal. Mach. Intell..

[3]  Danail Stoyanov,et al.  Implicit domain adaptation with conditional generative adversarial networks for depth prediction in endoscopy , 2019, International Journal of Computer Assisted Radiology and Surgery.

[4]  Quanzeng Wang,et al.  Endoscope field of view measurement. , 2017, Biomedical optics express.

[5]  C. Ponting,et al.  Single cell RNA-seq reveals profound transcriptional similarity between Barrett’s oesophagus and oesophageal submucosal glands , 2018, Nature Communications.

[6]  W. Hop,et al.  Risk factors for the development of an adenocarcinoma in columnar‐lined (Barrett) esophagus , 1993, Cancer.

[7]  Ryan Schmidt,et al.  meshmixer: an interface for rapid mesh composition , 2010, SIGGRAPH '10.

[8]  D. Faigel,et al.  Risk Factors for Dysplasia in Patients with Barrett's Esophagus (BE): Results from a Multicenter Consortium , 2003, Digestive Diseases and Sciences.

[9]  Prateek Sharma,et al.  Significantly lower annual rates of neoplastic progression in short- compared to long-segment non-dysplastic Barrett’s esophagus: a systematic review and meta-analysis , 2019, Endoscopy.

[10]  R. Sampliner,et al.  Lower Annual Rate of Progression of Short‐Segment vs Long‐Segment Barrett's Esophagus to Esophageal Adenocarcinoma , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[12]  A. Rastogi,et al.  Practice patterns among U.S. gastroenterologists regarding endoscopic management of Barrett's esophagus. , 2013, Gastrointestinal endoscopy.

[13]  Rebecca C Fitzgerald,et al.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus , 2013, Gut.

[14]  N. Shaheen,et al.  Recurrent intestinal metaplasia after radiofrequency ablation for Barrett's esophagus: endoscopic findings and anatomic location. , 2015, Gastrointestinal endoscopy.

[15]  E. Montgomery,et al.  Columnar islands in Barrett's esophagus: Do they impact Prague C&M criteria and dysplasia grade? , 2017, Journal of gastroenterology and hepatology.

[16]  A. Gavin,et al.  Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. , 2011, Journal of the National Cancer Institute.

[17]  H. Sørensen,et al.  Incidence of adenocarcinoma among patients with Barrett's esophagus. , 2011, The New England journal of medicine.

[18]  Nicholas J Shaheen,et al.  ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus , 2016, The American Journal of Gastroenterology.

[19]  R. Sampliner,et al.  Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  H. El‐Serag,et al.  Factors Associated With Recurrence of Barrett's Esophagus After Radiofrequency Ablation , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.